Fungal Infections in Boston Keratoprosthesis Patients: Lessons Learned and Novel Developments on the Horizon

REFERENCES

• Ma JJ, Graney JM, Dohlman CH. Repeat penetrating keratoplasty versus the Boston keratoprosthesis in graft failure. Int Ophthalmol Clin 2005;45(4):49–59
   PubMedGoogle Scholar
• Bersudsky V, Blum-Hareuveni T, Rehany U, Rumelt S. The profile of repeated corneal transplantation. Ophthalmology 2001;108(3):461–469
   PubMed Web of Science ®Google Scholar
• Pujari S, Siddique SS, Dohlman CH, Chodosh J. The Boston keratoprosthesis type II: the Massachusetts Eye and Ear Infirmary experience. Cornea 2011;30(12):1298–1303
   PubMed Web of Science ®Google Scholar
• Durand ML, Dohlman CH. Successful prevention of bacterial endophthalmitis in eyes with the Boston keratoprosthesis. Cornea 2009;28(8):896–901
   PubMed Web of Science ®Google Scholar
• Barnes SD, Dohlman CH, Durand ML. Fungal colonization and infection in Boston keratoprosthesis. Cornea 2007;26(1):9–15
   PubMed Web of Science ®Google Scholar
• Khan BF, Harissi-Dagher M, Pavan-Langston D, et al. The Boston keratoprosthesis in herpetic keratitis. Arch Ophthalmol 2007;125(6):745–749
   PubMedGoogle Scholar
• Aldave AJ, Kamal KM, Vo RC, Yu F. The Boston type I keratoprosthesis: improving outcomes and expanding indications. Ophthalmology 2009;116(4):640–651
   PubMed Web of Science ®Google Scholar
• Basu S, Taneja M, Naryanan R, et al. Short-term outcome of Boston type 1 keratoprosthesis for bilateral limbal stem cell deficiency. Indian J Ophthalmol 2012;60(2):151–153
   PubMed Web of Science ®Google Scholar
• Chan CC, Holland EJ. Infectious keratitis after Boston type 1 keratoprosthesis implantation. Cornea 2012;31(10):1128–1134
   PubMed Web of Science ®Google Scholar
• Chan CC, Holland EJ. Infectious endophthalmitis after Boston type 1 keratoprosthesis implantation. Cornea 2012;31(4):346–349
   PubMed Web of Science ®Google Scholar
• Utine CA, Tzu JH, Akpek EK. Clinical features and prognosis of Boston type I keratoprosthesis-associated corneal melt. Ocul Immunol Inflamm 2011;19(6):413–418
   PubMed Web of Science ®Google Scholar
• Rai R, Shorter E, Cortina MS, et al. Contact lens surveillance cultures in Boston type 1 keratoprosthesis patients. Eye Contact Lens 2013;39(2):175–178
   PubMed Web of Science ®Google Scholar
• Robert MC, Moussally K, Harissi-Dagher M. Review of endophthalmitis following Boston keratoprosthesis type 1. Br J Ophthalmol 2012;96(6):776–780
   PubMed Web of Science ®Google Scholar
• Chhablani J, Panchal B, Das T, et al. Erratum to: Endophthalmitis in Boston keratoprosthesis: case series and review of literature. Int Ophthalmol 2015;35(1):149–154
   Google Scholar
• Kim MJ, Yu F, Aldave AJ. Microbial keratitis after Boston type I keratoprosthesis implantation: incidence, organisms, risk factors, and outcomes. Ophthalmology 2013;120(11): 2209–2216
   PubMed Web of Science ®Google Scholar
• Behlau I, Martin KV, Martin JN, et al. Infectious endophthalmitis in Boston keratoprosthesis: incidence and prevention. Acta Ophthalmol 2014;92(7):e546–e555
   PubMed Web of Science ®Google Scholar
• Phillips DL, Hager JL, Goins KM, et al. Boston type 1 keratoprosthesis for chemical and thermal injury. Cornea 2014;33(9):905–909
   PubMed Web of Science ®Google Scholar
• Welder J, Greiner M, Wagoner M, et al. Prophylactic povidone-iodine rinses and topical Amphotericin-B significantly reduce postoperative infections after Boston Type I Keratoprosthesis. Presented at University of Iowa Hospitals & Clinics Department of Ophthalmology and Visual Sciences Research Day, Iowa, USA, April 2014
   Google Scholar
• Zerbe BL, Belin MW, Ciolino JB. Results from the multicenter Boston Type 1 Keratoprosthesis Study. Ophthalmology 2006;113(10):1779–1784
   PubMed Web of Science ®Google Scholar
• Ciolino JB, Belin MW, Todani A, et al. Retention of the Boston keratoprosthesis type 1: multicenter study results. Ophthalmology 2013;120(6):1195–1200
   PubMed Web of Science ®Google Scholar
• Lee SH, Mannis MJ, Shapiro B, et al. Evaluation of microbial flora in eyes with a Boston type 1 Keratoprosthesis. Cornea 2013;32(12):1537–1539
   PubMed Web of Science ®Google Scholar
• Greiner MA, Li JY, Mannis MJ. Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of California, Davis. Ophthalmology 2011;118(8):1543–1550
   PubMed Web of Science ®Google Scholar
• Magalhães FP, do Nascimento HM, Ecker DJ, et al. Microbiota evaluation of patients with a Boston type I keratoprosthesis treated with topical 0.5% moxifloxacin and 5% povidone-iodine. Cornea 2013;32(4):407–411
   PubMed Web of Science ®Google Scholar
• Nouri M, Terada H, Alfonso EC, et al. Endophthalmitis after keratoprosthesis: incidence, bacterial causes, and risk factors. Arch Ophthalmol 2001;119:484–489
   PubMedGoogle Scholar
• Robert MC, Eid EP, Saint-Antoine P, Harissi-Dagher M. Microbial colonization and antibacterial resistance patterns after Boston type 1 keratoprosthesis. Ophthalmology 2013;120(8):1521–1528
   PubMed Web of Science ®Google Scholar
• Ciralsky J, Papaliodis GN, Foster CS, et al. Keratoprosthesis in autoimmune disease. Ocul Immunol Inflamm 2010;18(4):275–280
   PubMed Web of Science ®Google Scholar
• Keating A, Pineda R. Trichosporon asahii keratitis in a patient with a type I Boston keratoprosthesis and contact lens. Eye Contact Lens 2012;38(2): 130–132
   PubMed Web of Science ®Google Scholar
• de Nascimento HM, de Oliveira LA, Höfling-Lima AL. Infectious keratitis in patients undergoing Boston Type 1 keratoprosthesis (Boston KPro) procedure: case series. Arq Bras Oftalmol 2011;74(2):127–129
   PubMed Web of Science ®Google Scholar
• Jain V, Mhatre K, Shome D, Pineda R. Fungal keratitis with the type 1 Boston keratoprosthesis: early Indian experience. Cornea 2012;31(7):841–843
   PubMed Web of Science ®Google Scholar
• Gallin JI, Zarember K. Lessons about the pathogenesis and management of aspergillosis from studies in chronic granulomatous disease. Trans Am Clin Climatol Assoc 2007;118:175–185
   PubMedGoogle Scholar
• Keay LJ, Gower EW, Iovieno A, et al. Clinical and microbiological characteristics of fungal keratitis in the United States, 2001–2007: a multicenter study. Ophthalmology 2011;118(5):920–926
   PubMed Web of Science ®Google Scholar
• Cardona H, DeVoe AG. Prosthokeratoplasty. Trans Sect Ophthalmol Am Acad Ophthalmol Otolaryngol 1977;83(2):271–280
   PubMedGoogle Scholar
• Harissi-Dagher M, Beyer J, Dohlman CH. The role of soft contact lenses as an adjunct to the Boston keratoprosthesis. Int Ophthalmol Clin 2008;48(2):43–51
   PubMedGoogle Scholar
• Wykoff CC, Flynn HW Jr., Miller D, et al. Exogenous fungal endophthalmitis: microbiology and clinical outcomes. Ophthalmology 2008;115(9):1501–1507
   PubMed Web of Science ®Google Scholar
• Hernandez-Camarena JC, Graue-Hernandez EO, Ortiz-Casas M, et al. Trends in microbiological and antibiotic sensitivity patterns in infectious keratitis: 10-year experience in Mexico City. Cornea 2015;34(7):778–785
   PubMed Web of Science ®Google Scholar
• Gopinathan U, Sharma S, Garg P, Rao GN. Review of epidemiological features, microbiological diagnosis and treatment outcome of microbial keratitis: experience of over a decade. Indian J Ophthalmol 2009;57(4):273–279
   PubMed Web of Science ®Google Scholar
• Xuguang S, Zhixin W, Zhiqun W, et al. Ocular fungal isolates and antifungal susceptibility in northern China. Am J Ophthalmol 2007;143(1):131–133
   PubMed Web of Science ®Google Scholar
• Knox CM, Cevellos V, Dean D. 16S ribosomal DNA typing for identification of pathogens in patients with bacterial keratitis. J Clin Microbiol 1998;36(12):3492–3496
   PubMed Web of Science ®Google Scholar
• O’Brien TP, Maguire MG, Fink NE, et al. Efficacy of ofloxacin vs cefazolin and tobramycin in the therapy for bacterial keratitis. Report from the Bacterial Keratitis Study Research Group. Arch Ophthalmol 1995;113(10):1257–1265
   PubMedGoogle Scholar
• Park SH, Lim JA, Choi JS, et al. The resistance patterns of normal ocular bacterial flora to 4 fluoroquinolone antibiotics. Cornea 2009;28(1):68–72
   PubMed Web of Science ®Google Scholar
• Williamson J, Gordon AM, Wood R, et al. Fungal flora of the conjunctival sac in health and disease. Influence of topical and systemic steroids. Br J Ophthalmol 1968;52(2):127–137
   PubMed Web of Science ®Google Scholar
• Ainley R, Smith B. Fungal flora of the conjunctival sac in healthy and diseased eyes. Br J Ophthalmol 1965;49(10):505–515
   PubMed Web of Science ®Google Scholar
• Rao PN, Rao KN. Study of the normal conjunctival flora (bacterial and fungal) and its relations to external ocular infections. Indian J Ophthalmol 1972;20(4):164–170
   PubMedGoogle Scholar
• Ando N, Takatori K. Fungal flora of the conjunctival sac. Am J Ophthalmol 1982;94(1):67–74
   PubMed Web of Science ®Google Scholar
• Fleiszig SM, Efron N. Microbial flora in eyes of current and former contact lens wearers. J Clin Microbiol 1992;30(5): 1156–1161
   PubMed Web of Science ®Google Scholar
• Bharathi MJ, Ramakrishnan R, Vasu S, et al. Epidemiological characteristics and laboratory diagnosis of fungal keratitis. A three-year study. Indian J Ophthalmol 2003;51(4):315–321
   PubMedGoogle Scholar
• Klotz SA, Penn CC, Negvesky GJ, Butrus SI. Fungal and parasitic infections of the eye. Clin Microbiol Rev 2000;13(4):662–685
   PubMed Web of Science ®Google Scholar
• Lin C, Lalitha P, Srinivasan M, et al. Seasonal trends of microbial keratitis in South India. Cornea 2012;31(10): 1123–1127
   PubMed Web of Science ®Google Scholar
• Trofa D, Gácser A, Nosanchuk JD. Candida parapsilosis, an emerging fungal pathogen. Clin Microbiol Rev 2008;21(4):606–625
   PubMed Web of Science ®Google Scholar
• Behlau I. Fungal infections revisited. Massachusetts Eye and Ear Infirmary Boston Keratoprosthesis Update, Newsletter VII 2010:3
   Google Scholar
• Abad JC. Novel strategies to improve keratoprosthesis outcomes. Presented at KPro Study Group Symposium, Shiley Eye Institute, San Diego, CA, USA, April 2015
   Google Scholar
• Amescua G. Infections. Presented at KPro Study Group Symposium, Shiley Eye Institute, San Diego, CA, USA, April 2015
   Google Scholar
• Thiel MA, Zinkernagel AS, Burhenne J, et al. Voriconazole concentration in human aqueous humor and plasma during topical or combined topical and systemic administration for fungal keratitis. Antimicrob Agents Chemother 2007;51(1):239–244
   PubMed Web of Science ®Google Scholar
• Hariprasad SM, Mieler WF, Lin TK, et al. Voriconazole in the treatment of fungal eye infections: a review of current literature. Br J Ophthalmol 2008;92(7):871–878
   PubMed Web of Science ®Google Scholar
• Chakrabarti A, Shivaprakash MR, Singh R, et al. Fungal endophthalmitis: fourteen years’ experience from a center in India. Retina 2008;28(10):1400–1407
   PubMed Web of Science ®Google Scholar
• Durand ML. Endophthalmitis. In: Principles and Practice of Infectious Diseases, 7th ed., vol. 1, G.L. Mandell, J.E. Bennett, R. Dolin eds. Philadelphia: Elsevier, 2010. p 1553
   Google Scholar
• Perez V, de la Cruz J, Cruzat A, Amescua G. Pan KPro Initiative. Presented at KPro Study Group Symposium, Shiley Eye Institute, San Diego, CA, USA, April 2015
   Google Scholar
• Tandon R. Setting up a keratoprosthesis service in a tertiary care public funded hospital in India. Presented at KPro Study Group Symposium, Shiley Eye Institute, San Diego, CA, USA, April 2015
   Google Scholar
• Muller R. Prognostic value of peri-prosthetic tissue loss for corneal melting: results of the longitudinal anterior segment OCT study in patients with Boston Type 1 Keratoprosthesis. Presented at KPro Study Group Symposium, Shiley Eye Institute, San Diego, CA, USA, April 2015
   Google Scholar
• Durkee H. KPro: What is the relationship between surface quality and biofilm adherence. Presented at KPro Study Group Symposium, Shiley Eye Institute, San Diego, CA, USA, April 2015
   Google Scholar
• Paschalis EI, Chodosh K, Spurr-Michaud S, et al. In vitro and in vivo assessment of titanium surface modification for coloring the backplate of the Boston keratoprosthesis. Invest Ophthalmol Vis Sci 2013;54(6):3863–3873
   PubMed Web of Science ®Google Scholar
• Paschalis E. Optimization of titanium surface characteristic in Boston Keratoprosthesis backplate. Presented at KPro Study Group Symposium, Shiley Eye Institute, San Diego, CA, USA, April 2015
   Google Scholar
• Odorcic S, Haas W, Gilmore MS, Dohlman CH. Fungal infections after Boston type 1 keratoprosthesis implantation: Literature review and in vitro antifungal activity of hypochlorous acid. Cornea 2015;34(12):1599–1605
   PubMed Web of Science ®Google Scholar